PIERUZZI FEDERICO UMBERTO EMILIO GUGLIE

Cortazar, F., Niles, J., Jayne, D., Merkel, P., Bruchfeld, A., Yue, H., et al. (2023). Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan. KIDNEY INTERNATIONAL REPORTS, 8(4), 860-870 [10.1016/j.ekir.2023.01.039]. Detail

Genovesi, S., Porcu, L., Rebora, P., Slaviero, G., Casu, G., Bertoli, S., et al. (2023). Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study. CLINICAL KIDNEY JOURNAL, 16(12), 2683-2692 [10.1093/ckj/sfad221]. Detail

Camporeale, A., Bandera, F., Pieroni, M., Pieruzzi, F., Spada, M., Bersano, A., et al. (2023). Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study. JOURNAL OF MEDICAL GENETICS, 60(9), 850-858 [10.1136/jmg-2022-108768]. Detail

Grassi, G., Fowler, B., Scali, B., Rossi, F., Motto, E., Pieruzzi, F., et al. (2022). Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease. JOURNAL OF HYPERTENSION, 40(8), 1530-1536 [10.1097/HJH.0000000000003179]. Detail

Salerno, F., Roggero, L., Rossi, F., Binaggia, A., Bertoli, S., Pieruzzi, F. (2022). Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy. CLINICAL KIDNEY JOURNAL, 15(1), 171-173 [10.1093/ckj/sfab148]. Detail